GMG
Clinical trials for GMG explained in plain language.
Never miss a new study
Get alerted when new GMG trials appear
Sign up with your email to follow new studies for GMG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New study tests Long-Term safety of efgartigimod for kids with rare muscle disease
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety of a drug called efgartigimod in children with generalized myasthenia gravis (gMG), a condition that causes muscle weakness. About 12 children who were in earlier studies will continue to receive the drug either through a vein or as a shot…
Matched conditions: GMG
Phase: PHASE2, PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated May 26, 2026 08:39 UTC
-
New hope for kids with rare muscle-weakening disease: drug trial underway
Disease control OngoingThis study tests a drug called ravulizumab in 12 children aged 6 to 18 with generalized myasthenia gravis, a condition that causes muscle weakness. The goal is to see how the drug works in the body, how safe it is, and whether it helps control symptoms like trouble moving or brea…
Matched conditions: GMG
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 08:32 UTC
-
New drug hope for rare Muscle-Weakening disease
Disease control OngoingThis study tests an investigational drug called efgartigimod given through a vein for adults with generalized myasthenia gravis (gMG) who do not have the usual acetylcholine receptor antibody. The goal is to see if it improves daily activities and muscle strength compared to a pl…
Matched conditions: GMG
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated May 20, 2026 11:53 UTC